Glucosylceramide modulates membrane traffic along the endocytic pathway.

Glucosylceramide modulates membrane traffic along the endocytic pathway.

Glycosphingolipids are endocytosed and targeted to the Golgi apparatus, but are mistargeted to lysosomes in numerous sphingolipidoses. Substrate reduction therapy utilizes imino sugars to inhibit glucosylceramide synthase and potentially abrogate the effects of storage. Gaucher disease is a heredita...

書目詳細資料
Main Authors:	Sillence, D, Puri, V, Marks, D, Butters, T, Dwek, R, Pagano, R, Platt, F
格式:	Journal article
語言:	English
出版:	2002

相似書籍

Glucosylceramide modulates membrane traffic along the endocytic pathway
由: Dan J. Sillence, et al.
出版: (2002-11-01)

Glycosphingolipids in endocytic membrane transport.
由: Sillence, D, et al.
出版: (2004)

Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
由: Norris-Cervetto, E, et al.
出版: (2004)

The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect.
由: Smith, D, et al.
出版: (2006)

Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis.
由: Walden, C, et al.
出版: (2007)

Can P-glycoprotein influence the bioavailability of iminosugar-based glucosylceramide synthase inhibitors?
由: Norris-Cervetto, E, et al.
出版: (2006)

Rabs, Rips, FIPs, and Endocytic Membrane Traffic
由: Rytis Prekeris
出版: (2003-01-01)

Regulation of the V-ATPase along the endocytic pathway occurs through reversible subunit association and membrane localization.
由: Céline Lafourcade, et al.
出版: (2008-07-01)

Glucosylceramide flippases contribute to cellular glucosylceramide homeostasis
由: Natsuki Kita, et al.
出版: (2024-03-01)

Small GTPases in post-Golgi and endocytic membrane traffic in Arabidopsis
由: Moore, I, et al.
出版: (2008)

Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease
由: Boucheron, C, et al.
出版: (2005)

A-RAF kinase functions in ARF6 regulated endocytic membrane traffic.
由: Elena Nekhoroshkova, et al.
出版: (2009-01-01)

Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the brain
由: Scott D. Larsen, et al.
出版: (2012-02-01)

Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation.
由: Mellor, H, et al.
出版: (2003)

Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide.
由: D'Angelo, G, et al.
出版: (2007)

Membrane order in the plasma membrane and endocytic recycling compartment.
由: David B Iaea, et al.
出版: (2017-01-01)

Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease (vol 16, pg 1747, 2005)
由: Boucheron, C, et al.
出版: (2005)

Glycosphingolipid changes in plasma in Parkinson’s disease independent of glucosylceramide levels
由: te Vruchte, D, et al.
出版: (2022)

Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling.
由: Neville, D, et al.
出版: (2004)

Assay for the transbilayer distribution of glycolipids: selective oxidation of glucosylceramide to glucuronylceramide by TEMPO nitroxyl radicals
由: Daniel J. Sillence, et al.
出版: (2000-08-01)

Invariant chain regulation of MHC class II function in the secretory and endocytic pathways
由: Germain, R, et al.
出版: (1997)

Glucosylceramides of pig epidermis: structure determination.
由: P W Wertz, et al.
出版: (1983-09-01)

Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids.
由: Garner, B, et al.
出版: (2002)

Editorial: Signaling Control by Compartmentalization Along the Endocytic Route
由: Costin N. Antonescu, et al.
出版: (2019-10-01)

Glucosylceramide is essential for Heartland and Dabie bandavirus glycoprotein-induced membrane fusion.
由: Tian Xia, et al.
出版: (2023-03-01)

Glucosylceramide is essential for Heartland and Dabie bandavirus glycoprotein-induced membrane fusion
由: Tian Xia, et al.
出版: (2023-03-01)

Lipids regulate the hydrolysis of membrane bound glucosylceramide by lysosomal β-glucocerebrosidase
由: Misbaudeen Abdul-Hammed, et al.
出版: (2017-03-01)

Sitosterol and glucosylceramide cooperative transversal and lateral uneven distribution in plant membranes
由: V. Rondelli, et al.
出版: (2021-11-01)

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses
由: Butters, T, et al.
出版: (2005)

Therapeutic applications of imino sugars in lysosomal storage disorders.
由: Butters, T, et al.
出版: (2003)

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
由: Butters, T, et al.
出版: (2005)

New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
由: Butters, T, et al.
出版: (2003)

Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
由: Butters, T, et al.
出版: (2000)

Inhibition of membrane-associated viral replication
由: Block, T, et al.
出版: (2016)

Cytosolic glucosylceramide regulates endolysosomal function in Niemann-Pick type C disease
由: Simon Wheeler, et al.
出版: (2019-07-01)

Imino sugar therapy for type 1 Gaucher disease.
由: Priestman, D, et al.
出版: (2000)

Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model.
由: Sonya Barnes, et al.
出版: (2014-01-01)

Membrane binding of plasmid DNA and endocytic pathways are involved in electrotransfection of mammalian cells.
由: Mina Wu, et al.
出版: (2011-01-01)

Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity.
由: Gerrard, G, et al.
出版: (2009)

Permeability Barrier and Microstructure of Skin Lipid Membrane Models of Impaired Glucosylceramide Processing
由: Michaela Sochorová, et al.
出版: (2017-07-01)